Question 1

Can we publish our success rates in Singapore?

Accepted Answer

You can present outcome data, but not as a competitive weapon, and the distinction is where most fertility marketing in this market goes wrong. Superiority claims are not permitted under Singapore's advertising rules, so a headline figure positioned to imply your clinic outperforms others fails regardless of whether the number is accurate. There is also a well-understood problem with raw success rates in fertility specifically: they are trivially manipulated through case selection. A clinic that declines difficult cases posts better figures than one accepting poor-prognosis patients, which means an unqualified percentage misleads the reader even when nobody intended it to. The defensible approach is to publish outcomes as patient education with the context that makes them interpretable. Break figures down by maternal age band, because age is the dominant variable and a single clinic-wide number conceals it entirely. Distinguish per-cycle from cumulative rates across multiple cycles, which patients routinely conflate. Distinguish clinical pregnancy from live birth. State the population the figures describe and the period they cover. Explain what shifts an individual's prospects away from the average — diagnosis, ovarian reserve, prior cycles, male factor. Presented that way, the data helps a couple form realistic expectations, which is genuinely useful and reads as honesty rather than promotion. It also tends to attract better-prepared patients, since anyone drawn in by an inflated headline figure eventually becomes a disappointed one.

Question 2

How should government co-funding shape our marketing and enquiry handling?

Accepted Answer

It should sit at the centre of both, because for a large share of Singapore couples the funding question determines whether treatment happens at all. Government co-funding is available to eligible citizens and permanent residents for assisted reproduction cycles at approved providers, subject to conditions and cycle limits, and it changes the economics of treatment substantially. Yet clinic websites routinely mention it in a single line, leaving couples to work out eligibility from official sources and arrive at the consultation with the wrong expectation in either direction. Build the explainer properly. Cover who qualifies, the conditions that apply, how many cycles are supported, how Medisave interacts with the remaining balance, and — the part that actually gets read — a worked illustration of what a couple in a given situation still pays per attempt. Note that eligibility rules change periodically and give the page an owner, because outdated funding information is worse than none at all. Keep the framing factual and educational rather than promotional; presenting co-funding as a deal or an incentive to proceed sits badly against the restrictions on inducements. Then align enquiry handling to match. Whoever answers the phone should be able to walk through eligibility confidently, and your intake should capture residency status early, since the entire conversation differs for a foreign national or a regional patient with no access to co-funding at all.

Question 3

How do we market to fertility patients over a research cycle this long?

Accepted Answer

With patience and considerably more restraint than most performance marketing allows. Fertility decisions commonly take six to eighteen months from first search to first consultation, and much of that period is spent anonymously — reading about a diagnosis, absorbing what a cycle involves, working out the money, deciding whether to tell anyone. Campaigns optimised toward a fast conversion misread this audience entirely and burn expensive Singapore clicks on people who were never going to enquire that week. The approach that works treats the research period as the product. Build genuinely comprehensive education for each stage: initial investigation and what tests mean, specific diagnoses in depth, treatment options from ovulation induction through IUI to IVF and ICSI, the co-funding arithmetic, what a cycle involves week by week, and — often the most valuable and most neglected — what happens after a cycle fails. Let people subscribe to material that is useful rather than promotional, and measure the programme on qualified consultations rather than weekly lead volume. Two Singapore-specific cautions. Remarketing to fertility patients requires real care: creative following someone around the internet after a failed cycle or a pregnancy is distressing, and PDPA obligations around consent, purpose limitation and retention deserve strict handling for data this sensitive. And the regional segment from Indonesia and Malaysia runs on a different track entirely, with no co-funding access and a different set of practical questions about travelling for treatment.

Question 4

What does ivf & fertility marketing cost in Singapore?

Accepted Answer

We quote clients in Singapore in SGD. Google Business Profile management starts around SGD 85 per month and full-service retainers from about SGD 370 per month, scoped to how competitive your specialty and catchment are. IVF & Fertility is among the more contested categories in this market, so expect scope at the higher end where you are competing in a major city. Those figures are converted from our India list at an indicative rate and confirmed in writing after the free audit. Paid media sits outside our fee — in Singapore treatment-intent clicks typically run S$5–25.

Question 5

How quickly do ivf & fertility clinics see results in Singapore?

Accepted Answer

Profile views, calls and direction requests usually move within 30 days, because the first wins come from fixing what is already indexed. Ranking and pipeline change typically lands between 60 and 90 days. IVF & Fertility has a longer consideration window than routine care — patients research, compare and often revisit over weeks — so the enquiry that arrives in month two frequently started in month one. We report against booked consultations rather than impressions for exactly that reason, and we sequence work so there is early traction on winnable searches while the contested head terms build.

IVF & Fertility marketing in Singapore

Why this market behaves differently.

How they actually choose a clinic in Singapore.

Private research

Funding arithmetic

Clinician selection

First consultation and beyond

The plays that work for this specialty in Singapore.

The co-funding explainer as flagship content

Diagnosis-led education depth

Careful outcome framing

Long-cycle nurture, handled gently

What the rules mean for ivf & fertility.